Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

DreaMed Diabetes

DreaMed Diabetes
2014 FOUNDED
PRIVATE STATUS
21-30 EMPLOYEES
Early Stage VC LATEST DEAL TYPE
$1.21M LATEST DEAL AMOUNT
6 INVESTORS
Description

Developer of a diabetes management system designed for the optimization of intensive insulin therapy. The company's system uses event-driven machine learning and logic technology in order to process multiple personalized parameters such as insulin delivery data, glucose readings, meal data and optimized insulin dosing treatment plan, enabling clients to improve their quality of life and lowers their overall treatment costs.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Decision/Risk Analysis
Other Industries
Therapeutic Devices
Primary Office
  • 5 Mota Gur Street
  • Petah Tikva 4952701
  • Israel
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore DreaMed Diabetes’s full profile, request a free trial.

DreaMed Diabetes Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC $1.21M 00.000 Completed Generating Revenue
3. Early Stage VC 01-Jul-2016 00.00 00.00 Completed Generating Revenue
2. Grant 03-Feb-2016 $3.4M $2M Completed Generating Revenue
1. Angel (individual) 06-Apr-2015 $2M $2M Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

DreaMed Diabetes Competitors (4)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Valeritas Formerly VC-backed Bridgewater, NJ 00 00000 000000000 00000
0000000 0000000000 Venture Capital-Backed Milpitas, CA 00 000.00 00000000000 000.00
00000 00000000 Private Equity-Backed San Francisco, CA 00 000.00 0000000 0000 000.00
00000000 Venture Capital-Backed Paris, France 00 00000 0000000000 0 00000
To view this company’s complete list of competitors, request access »

DreaMed Diabetes Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Millhouse Asset Manager Minority 000 0000 000000 0
Norma Investments Venture Capital Minority 000 0000 000000 0
The Leona M. and Harry B. Helmsley Charitable Trust Lender/Debt Provider Minority 000 0000 000000 0
Medtronic Corporation Minority 000 0000 000000 0
Roman Abramovich Angel (individual) Minority 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »

DreaMed Diabetes Executive Team (10)

Name Title Board
Seat
Contact
Info
Eran Atlas Co-Founder & Chief Executive Officer
Etti Hanochi Chief Financial Officer
Tadej Battelino Chief Clinical
Revital Nimri Chief Medical R&D Officer & Co-Founder
Eran Agmon Chief Product Officer

4 Former Executives

You’re viewing 5 of 10 executives. Get the full list »

DreaMed Diabetes Board Members (1)

Name Representing Role Since Contact
Info
Moshe Phillip Self Co-Founder, Chief Science Officer & Chairman 000 0000